Exicure to Present at Upcoming Conferences
September 10 2020 - 7:00AM
Business Wire
Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and
immunotherapeutic drugs utilizing spherical nucleic acid (SNA™)
constructs, today announced presentations at the following
conferences during the month of September:
- TIDES: Oligonucleotide & Peptide Therapeutics Panel
discussion: The impact of technological advances in the TIDES Space
Presented by: CEO David Giljohann Tuesday, September 15, 2020 Panel
Discussion: Streamlining the transition from discovery to
manufacturing Presented by: Vice President of Translational
Research Weston Daniel Tuesday, September 15, 2020
- H.C. Wainwright 22nd Annual Global Investment Conference
Corporate update Presented by: CEO David Giljohann Tuesday,
September 15, 2020 at 1:00pm ET
Replays of the H.C. Wainwright webcast will be available on
Exicure’s website for 90 days following the webcast.
About Exicure, Inc.
Exicure, Inc. is a clinical-stage biotechnology company
developing therapeutics for neurology, immuno-oncology,
inflammatory diseases and other genetic disorders based on our
proprietary Spherical Nucleic Acid, or SNA technology. Exicure
believes that its proprietary SNA architecture has distinct
chemical and biological properties that may provide advantages over
other nucleic acid therapeutics and may have therapeutic potential
to target diseases not typically addressed with other nucleic acid
therapeutics. Exicure is in preclinical development of XCUR-FXN an
SNA–based therapeutic candidate, for the treatment of Friedreich’s
ataxia (FA). Exicure's drug candidate AST-008 is currently in a
Phase 1b/2 clinical trial in patients with advanced solid tumors.
Exicure is based outside of Chicago, IL and also has an office in
Cambridge, MA.
For more information, visit Exicure’s website at
www.exicuretx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200910005145/en/
MacDougall Karen Sharma 781-235-3060 ksharma@macbiocom.com
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jul 2023 to Jul 2024